9887 — Nanjing Leads Biolabs Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$12.67bn
- HK$11.21bn
- CNY177.26m
Annual cashflow statement for Nanjing Leads Biolabs Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -362 | -301 | -196 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 128 | 86 | 12.7 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 18.1 | 70.3 | 7.56 |
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -193 | -119 | -154 |
| Capital Expenditures | -11.7 | -2.98 | -10.4 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 147 | -64.3 | -155 |
| Sale of Fixed Assets | |||
| Change in Net Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 135 | -67.3 | -165 |
| Financing Cash Flow Items | -6.87 | -9.62 | -86.3 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 49.5 | 309 | 1,190 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -5 | 125 | 849 |